A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
While the COVID-19 pandemic has spurred intense research and collaborative discovery worldwide, the development of a safe, effective, and targeted antiviral from the ground up is time intensive. Therefore, most antiviral discovery efforts are focused on the re-purposing of clinical stage or approved...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
BioMed Central
2020
|
| Online Access: | https://hdl.handle.net/1721.1/128105 |